Localisation of an occult thyrotropinoma with $^{11}$C-methionine PET-CT before and after somatostatin analogue therapy

Autor: Koulouri, O, Hoole, AC, English, P, Allinson, K, Antoun, N, Cheow, H, Burnet, NG, Donnelly, N, Mannion, RJ, Gurnell, M

A 75-year-old woman presented to her local endocrine service with tiredness, palpitations, and enlargement of a longstanding goitre. Unexpectedly, her thyrotropin (thyroid-stimulating hormone [TSH]) concentration was not suppressed (6·3 mU/L; refere

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6adcbb895299cb54899a2a5a880330d5
https://www.repository.cam.ac.uk/handle/1810/261698

Applying physical science techniques and CERN technology to an unsolved problem in radiation treatment for cancer: the multidisciplinary 'VoxTox' research programme.

Autor: Burnet NG; Cancer Research UK VoxTox Research Group, University of Cambridge Department of Oncology, Cambridge Biomedical Campus, Addenbrooke's Hospital, Cambridge, CB2 0QQ, UK.; University of Cambridge Department of Oncology, Cambridge Biomedical Campus, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 0QQ, UK., Scaife JE; Cancer Research UK VoxTox Research Group, University of Cambridge Department of Oncology, Cambridge Biomedical Campus, Addenbrooke's Hospital, Cambridge, CB2 0QQ, UK.; University of Cambridge Department of Oncology, Cambridge Biomedical Campus, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 0QQ, UK., Romanchikova M; Cancer Research UK VoxTox Research Group, University of Cambridge Department of Oncology, Cambridge Biomedical Campus, Addenbrooke's Hospital, Cambridge, CB2 0QQ, UK.; Department of Medical Physics and Clinical Engineering, Addenbrooke's Hospital, Cambridge, CB2 0QQ, UK., Thomas SJ; Cancer Research UK VoxTox Research Group, University of Cambridge Department of Oncology, Cambridge Biomedical Campus, Addenbrooke's Hospital, Cambridge, CB2 0QQ, UK.; Department of Medical Physics and Clinical Engineering, Addenbrooke's Hospital, Cambridge, CB2 0QQ, UK., Bates AM; Cancer Research UK VoxTox Research Group, University of Cambridge Department of Oncology, Cambridge Biomedical Campus, Addenbrooke's Hospital, Cambridge, CB2 0QQ, UK.; Oncology Centre, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, CB2 0QQ, UK., Wong E; Cancer Research UK VoxTox Research Group, University of Cambridge Department of Oncology, Cambridge Biomedical Campus, Addenbrooke's Hospital, Cambridge, CB2 0QQ, UK.; Oncology Centre, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, CB2 0QQ, UK., Noble DJ; Cancer Research UK VoxTox Research Group, University of Cambridge Department of Oncology, Cambridge Biomedical Campus, Addenbrooke's Hospital, Cambridge, CB2 0QQ, UK.; Oncology Centre, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, CB2 0QQ, UK., Shelley LE; Cancer Research UK VoxTox Research Group, University of Cambridge Department of Oncology, Cambridge Biomedical Campus, Addenbrooke's Hospital, Cambridge, CB2 0QQ, UK.; Department of Engineering, University of Cambridge, Trumpington Street, Cambridge, CB2 1PZ, UK., Bond SJ; Cancer Research UK VoxTox Research Group, University of Cambridge Department of Oncology, Cambridge Biomedical Campus, Addenbrooke's Hospital, Cambridge, CB2 0QQ, UK.; Cambridge Clinical Trials Unit, Box 401, Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 0QQ, UK., Forman JR; Cancer Research UK VoxTox Research Group, University of Cambridge Department of Oncology, Cambridge Biomedical Campus, Addenbrooke's Hospital, Cambridge, CB2 0QQ, UK.; Cambridge Clinical Trials Unit, Box 401, Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 0QQ, UK., Hoole AC; Cancer Research UK VoxTox Research Group, University of Cambridge Department of Oncology, Cambridge Biomedical Campus, Addenbrooke's Hospital, Cambridge, CB2 0QQ, UK.; Department of Medical Physics and Clinical Engineering, Addenbrooke's Hospital, Cambridge, CB2 0QQ, UK., Barnett GC; Cancer Research UK VoxTox Research Group, University of Cambridge Department of Oncology, Cambridge Biomedical Campus, Addenbrooke's Hospital, Cambridge, CB2 0QQ, UK.; Oncology Centre, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, CB2 0QQ, UK., Brochu FM; Cancer Research UK VoxTox Research Group, University of Cambridge Department of Oncology, Cambridge Biomedical Campus, Addenbrooke's Hospital, Cambridge, CB2 0QQ, UK.; Cavendish Laboratory, University of Cambridge, JJ Thomson Avenue, Cambridge, CB3 0HE, UK., Simmons MP; Cancer Research UK VoxTox Research Group, University of Cambridge Department of Oncology, Cambridge Biomedical Campus, Addenbrooke's Hospital, Cambridge, CB2 0QQ, UK.; Cavendish Laboratory, University of Cambridge, JJ Thomson Avenue, Cambridge, CB3 0HE, UK., Jena R; Cancer Research UK VoxTox Research Group, University of Cambridge Department of Oncology, Cambridge Biomedical Campus, Addenbrooke's Hospital, Cambridge, CB2 0QQ, UK.; University of Cambridge Department of Oncology, Cambridge Biomedical Campus, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 0QQ, UK., Harrison K; Cancer Research UK VoxTox Research Group, University of Cambridge Department of Oncology, Cambridge Biomedical Campus, Addenbrooke's Hospital, Cambridge, CB2 0QQ, UK.; Cavendish Laboratory, University of Cambridge, JJ Thomson Avenue, Cambridge, CB3 0HE, UK., Yeap PL; Cancer Research UK VoxTox Research Group, University of Cambridge Department of Oncology, Cambridge Biomedical Campus, Addenbrooke's Hospital, Cambridge, CB2 0QQ, UK.; Cavendish Laboratory, University of Cambridge, JJ Thomson Avenue, Cambridge, CB3 0HE, UK., Drew A; Cancer Research UK VoxTox Research Group, University of Cambridge Department of Oncology, Cambridge Biomedical Campus, Addenbrooke's Hospital, Cambridge, CB2 0QQ, UK.; Cavendish Laboratory, University of Cambridge, JJ Thomson Avenue, Cambridge, CB3 0HE, UK., Silvester E; Cancer Research UK VoxTox Research Group, University of Cambridge Department of Oncology, Cambridge Biomedical Campus, Addenbrooke's Hospital, Cambridge, CB2 0QQ, UK.; Cavendish Laboratory, University of Cambridge, JJ Thomson Avenue, Cambridge, CB3 0HE, UK., Elwood P; Cancer Research UK VoxTox Research Group, University of Cambridge Department of Oncology, Cambridge Biomedical Campus, Addenbrooke's Hospital, Cambridge, CB2 0QQ, UK.; Cavendish Laboratory, University of Cambridge, JJ Thomson Avenue, Cambridge, CB3 0HE, UK., Pullen H; Cancer Research UK VoxTox Research Group, University of Cambridge Department of Oncology, Cambridge Biomedical Campus, Addenbrooke's Hospital, Cambridge, CB2 0QQ, UK.; Cavendish Laboratory, University of Cambridge, JJ Thomson Avenue, Cambridge, CB3 0HE, UK., Sultana A; Cancer Research UK VoxTox Research Group, University of Cambridge Department of Oncology, Cambridge Biomedical Campus, Addenbrooke's Hospital, Cambridge, CB2 0QQ, UK.; Cavendish Laboratory, University of Cambridge, JJ Thomson Avenue, Cambridge, CB3 0HE, UK., Seah SY; Cancer Research UK VoxTox Research Group, University of Cambridge Department of Oncology, Cambridge Biomedical Campus, Addenbrooke's Hospital, Cambridge, CB2 0QQ, UK.; Cavendish Laboratory, University of Cambridge, JJ Thomson Avenue, Cambridge, CB3 0HE, UK., Wilson MZ; Cancer Research UK VoxTox Research Group, University of Cambridge Department of Oncology, Cambridge Biomedical Campus, Addenbrooke's Hospital, Cambridge, CB2 0QQ, UK.; Cavendish Laboratory, University of Cambridge, JJ Thomson Avenue, Cambridge, CB3 0HE, UK., Russell SG; Cancer Research UK VoxTox Research Group, University of Cambridge Department of Oncology, Cambridge Biomedical Campus, Addenbrooke's Hospital, Cambridge, CB2 0QQ, UK.; Oncology Centre, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, CB2 0QQ, UK., Benson RJ; Cancer Research UK VoxTox Research Group, University of Cambridge Department of Oncology, Cambridge Biomedical Campus, Addenbrooke's Hospital, Cambridge, CB2 0QQ, UK.; Oncology Centre, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, CB2 0QQ, UK., Rimmer YL; Cancer Research UK VoxTox Research Group, University of Cambridge Department of Oncology, Cambridge Biomedical Campus, Addenbrooke's Hospital, Cambridge, CB2 0QQ, UK.; Oncology Centre, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, CB2 0QQ, UK., Jefferies SJ; Cancer Research UK VoxTox Research Group, University of Cambridge Department of Oncology, Cambridge Biomedical Campus, Addenbrooke's Hospital, Cambridge, CB2 0QQ, UK.; Oncology Centre, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, CB2 0QQ, UK., Taku N; Cancer Research UK VoxTox Research Group, University of Cambridge Department of Oncology, Cambridge Biomedical Campus, Addenbrooke's Hospital, Cambridge, CB2 0QQ, UK.; University of Cambridge Department of Oncology, Cambridge Biomedical Campus, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 0QQ, UK., Gurnell M; Cancer Research UK VoxTox Research Group, University of Cambridge Department of Oncology, Cambridge Biomedical Campus, Addenbrooke's Hospital, Cambridge, CB2 0QQ, UK.; Metabolic Research Laboratories, Wellcome Trust-MRC Institute of Metabolic Science, University of Cambridge and National Institute for Health Research, Cambridge Biomedical Research Campus, Addenbrooke's Hospital, Cambridge, UK, CB2 0QQ, UK., Powlson AS; Cancer Research UK VoxTox Research Group, University of Cambridge Department of Oncology, Cambridge Biomedical Campus, Addenbrooke's Hospital, Cambridge, CB2 0QQ, UK.; Metabolic Research Laboratories, Wellcome Trust-MRC Institute of Metabolic Science, University of Cambridge and National Institute for Health Research, Cambridge Biomedical Research Campus, Addenbrooke's Hospital, Cambridge, UK, CB2 0QQ, UK., Schönlieb CB; Cancer Research UK VoxTox Research Group, University of Cambridge Department of Oncology, Cambridge Biomedical Campus, Addenbrooke's Hospital, Cambridge, CB2 0QQ, UK.; Department of Applied Mathematics and Theoretical Physics, Centre for Mathematical Sciences, University of Cambridge, Wilberforce Road, Cambridge, CB3 0WA, UK., Cai X; Cancer Research UK VoxTox Research Group, University of Cambridge Department of Oncology, Cambridge Biomedical Campus, Addenbrooke's Hospital, Cambridge, CB2 0QQ, UK.; Mullard Space Science Laboratory (MSSL), University College London, Surrey, RH5 6NT, UK., Sutcliffe MP; Cancer Research UK VoxTox Research Group, University of Cambridge Department of Oncology, Cambridge Biomedical Campus, Addenbrooke's Hospital, Cambridge, CB2 0QQ, UK.; Cavendish Laboratory, University of Cambridge, JJ Thomson Avenue, Cambridge, CB3 0HE, UK., Parker MA; Cancer Research UK VoxTox Research Group, University of Cambridge Department of Oncology, Cambridge Biomedical Campus, Addenbrooke's Hospital, Cambridge, CB2 0QQ, UK.; Cavendish Laboratory, University of Cambridge, JJ Thomson Avenue, Cambridge, CB3 0HE, UK.

Publikováno v: CERN ideaSquare journal of experimental innovation [CERN Ideasq J Exp Innov] 2017 Jun; Vol. 1 (1), pp. 3-12.

Successful treatment of residual pituitary adenoma in persistent acromegaly following localisation by 11C-methionine PET co-registered with MRI.

Autor: Koulouri O; Metabolic Research LaboratoriesWellcome Trust-MRC Institute of Metabolic Science., Kandasamy N; Metabolic Research LaboratoriesWellcome Trust-MRC Institute of Metabolic Science., Hoole AC; Department of Medical Physics., Gillett D; Department of Nuclear Medicine., Heard S; Department of Nuclear Medicine., Powlson AS; Metabolic Research LaboratoriesWellcome Trust-MRC Institute of Metabolic Science., O'Donovan DG; Department of Pathology., Annamalai AK; Metabolic Research LaboratoriesWellcome Trust-MRC Institute of Metabolic Science., Simpson HL; Metabolic Research LaboratoriesWellcome Trust-MRC Institute of Metabolic Science., Akker SA; Department of EndocrinologySt Bartholomew's Hospital, London, UK., Aylwin SJ; Department of EndocrinologyKing's College Hospital, London, UK., Brooke A; Macleod Diabetes and Endocrine CentreRoyal Devon and Exeter Hospital, Exeter, UK., Buch H; Department of Diabetes and EndocrinologyNew Cross Hospital, Wolverhampton, UK., Levy MJ; Department of EndocrinologyLeicester Royal Infirmary, Leicester, UK., Martin N; Department of EndocrinologyImperial College Healthcare NHS Trust, London, UK., Morris D; Diabetes and Endocrine CentreIpswich Hospital, Ipswich, UK., Parkinson C; Diabetes and Endocrine CentreIpswich Hospital, Ipswich, UK., Tysome JR; Department of Otolaryngology., Santarius T; Department of Neurosurgery., Donnelly N; Department of Otolaryngology., Buscombe J; Department of Nuclear Medicine., Boros I; Wolfson Brain Imaging CentreUniversity of Cambridge and National Institute for Health Research Cambridge Biomedical Research Centre, Addenbrooke's Hospital, Cambridge, UK., Smith R; Wolfson Brain Imaging CentreUniversity of Cambridge and National Institute for Health Research Cambridge Biomedical Research Centre, Addenbrooke's Hospital, Cambridge, UK., Aigbirhio F; Wolfson Brain Imaging CentreUniversity of Cambridge and National Institute for Health Research Cambridge Biomedical Research Centre, Addenbrooke's Hospital, Cambridge, UK., Antoun NM; Department of Neuroradiology., Burnet NG; Department of Oncology., Cheow H; Department of Nuclear Medicine., Mannion RJ; Department of Neurosurgery., Pickard JD; Department of Neurosurgery Wolfson Brain Imaging CentreUniversity of Cambridge and National Institute for Health Research Cambridge Biomedical Research Centre, Addenbrooke's Hospital, Cambridge, UK., Gurnell M; Metabolic Research LaboratoriesWellcome Trust-MRC Institute of Metabolic Science mg299@medschl.cam.ac.uk.

Publikováno v: European journal of endocrinology [Eur J Endocrinol] 2016 Nov; Vol. 175 (5), pp. 485-498. Date of Electronic Publication: 2016 Aug 25.

Image guidance protocols: balancing imaging parameters against scan time.

Autor: Bates AM; Cancer Research UK VoxTox Research Group, Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK., Scaife JE, Tudor GS, Jena R, Romanchikova M, Dean JC, Hoole AC, Simmons MP, Burnet NG

Publikováno v: The British journal of radiology [Br J Radiol] 2013 Dec; Vol. 86 (1032), pp. 20130385. Date of Electronic Publication: 2013 Oct 15.

Practical aspects of implementation of helical tomotherapy for intensity-modulated and image-guided radiotherapy.

Autor: Burnet NG; University of Cambridge Department of Oncology, Oncology Centre, Addenbrooke's Hospital, Cambridge, UK. ngb21@cam.ac.uk, Adams EJ, Fairfoul J, Tudor GS, Hoole AC, Routsis DS, Dean JC, Kirby RD, Cowen M, Russell SG, Rimmer YL, Thomas SJ

Publikováno v: Clinical oncology (Royal College of Radiologists (Great Britain)) [Clin Oncol (R Coll Radiol)] 2010 May; Vol. 22 (4), pp. 294-312. Date of Electronic Publication: 2010 Mar 29.